Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

NHS mandate

- PMLiVE

Inventor turns bomb detector into cancer breathalyser

Clinical trials of Billy Boyle's device will be held in two NHS hospitals

- PMLiVE

ABPI names Amgen’s UK head as president

John Kearney replaces Pfizer’s Jonathan Emms

UK flag

No further price cut for non-PPRS drugs in UK

But industry concerned over long-term plan for statutory medicines on the NHS

- PMLiVE

NICE consults on reducing melanoma cases

New guidance set to focus on diagnosing and managing the skin cancer  

- PMLiVE

Novartis launches another localised NHS eye service in UK

Will provide specialised care to people of Coventry

- PMLiVE

Cancer deaths in young people in UK drop by 58% in 40 years

Figures released by Cancer Research UK

- PMLiVE

Virginia Acha leaves Amgen for ABPI

Joins UK pharma trade body as director of research, medical and innovation

- PMLiVE

CDF chair regrets undermining NICE

But Prof Clark says he wholeheartedly supports the Institute

ABPI London offices

ABPI: Put value-based assessment back on the agenda

Industry body wants stalled project to be revived in a broad context that would include NICE reform

- PMLiVE

NHS England reveals plan to improve cancer survival rates

Independent taskforce to be led by Cancer Research UK’s chief executive

- PMLiVE

NICE set to dismiss Millennium’s Crohn’s drug Entyvio

Body cites uncertain evidence and unlikely value for the NHS

- PMLiVE

Pfizer’s Dr Simon Campbell recognised in UK’s New Year Honours

Recipients also include NICE’s Professor Carole Longson

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links